Status:
COMPLETED
Molecular Epidemiology of Cutaneous Malignant Melanoma
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Melanoma
Eligibility:
All Genders
18-100 years
Brief Summary
This case-control study was planned to investigate the link of solar radiation with gene damage, host factors, and DNA repair proficiency in cutaneous malignant melanoma (CMM) risk. The hypothesis was...
Detailed Description
The original case-control study was planned to investigate the link of solar radiation with gene damage, host factors, including also genetic variants, and DNA repair proficiency in cutaneous malignan...
Eligibility Criteria
Inclusion
- Analysis on samples already collected.
Exclusion
Key Trial Info
Start Date :
November 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 26 2020
Estimated Enrollment :
15401 Patients enrolled
Trial Details
Trial ID
NCT00341991
Start Date
November 1 2001
End Date
June 26 2020
Last Update
June 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892